These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19483329)

  • 21. Preparation and evaluation of orally rapidly disintegrating tablets containing taste-masked particles using one-step dry-coated tablets technology.
    Kondo K; Niwa T; Ozeki Y; Ando M; Danjo K
    Chem Pharm Bull (Tokyo); 2011; 59(10):1214-20. PubMed ID: 21963629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the disintegration properties of microcrystalline cellulose II and commercial disintegrants.
    Rojas J; Kumar V
    Pharmazie; 2012 Jun; 67(6):500-6. PubMed ID: 22822537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some factors affecting properties and dissolution behavior of tableted furosemide microspheres.
    Akbuğa J
    Pharmazie; 1992 Feb; 47(2):128-31. PubMed ID: 1635921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and evaluation of ritodrine buccal tablets for rational therapeutic use.
    Onishi H; Yumoto K; Sakata O
    Int J Pharm; 2014 Jul; 468(1-2):207-13. PubMed ID: 24709218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
    Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
    Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method.
    Ishikawa T; Watanabe Y; Utoguchi N; Matsumoto M
    Chem Pharm Bull (Tokyo); 1999 Oct; 47(10):1451-4. PubMed ID: 10553641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: evaluation of wetting and disintegration of tablet on the basis of surface free energy.
    Fukami J; Ozawa A; Yoshihashi Y; Yonemochi E; Terada K
    Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1536-9. PubMed ID: 16327184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of non-water-soluble placebo pellets of different sizes on the characteristics of orally disintegrating tablets manufactured by freeze-drying.
    Stange U; Führling C; Gieseler H
    J Pharm Sci; 2013 Jun; 102(6):1786-1799. PubMed ID: 23568590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
    Bi Y; Sunada H; Yonezawa Y; Danjo K; Otsuka A; Iida K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2121-7. PubMed ID: 8945778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral disintegrating patient-tailored tablets of warfarin sodium produced by 3D printing.
    Tian P; Yang F; Xu Y; Lin MM; Yu LP; Lin W; Lin QF; Lv ZF; Huang SY; Chen YZ
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1918-1923. PubMed ID: 30027774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Ceolus™ microcrystalline cellulose grades for the direct compression of enteric-coated pellets.
    Kucera SU; DiNunzio JC; Kaneko N; McGinity JW
    Drug Dev Ind Pharm; 2012 Mar; 38(3):341-50. PubMed ID: 21870908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enalapril maleate orally disintegrating tablets: tableting and in vivo evaluation in hypertensive rats.
    Tawfeek HM; Faisal W; Soliman GM
    Pharm Dev Technol; 2018 Jun; 23(5):496-503. PubMed ID: 28489472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of drug loading capacity of cellactose with two ad hoc processed lactose-cellulose direct compression excipients.
    Casalderrey M; Souto C; Concheiro A; Gómez-Amoza JL; Martínez-Pacheco R
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):398-401. PubMed ID: 15056951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous direct tablet compression: effects of impeller rotation rate, total feed rate and drug content on the tablet properties and drug release.
    Järvinen MA; Paaso J; Paavola M; Leiviskä K; Juuti M; Muzzio F; Järvinen K
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1802-8. PubMed ID: 23163644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
    Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets.
    Yan YD; Woo JS; Kang JH; Yong CS; Choi HG
    Biol Pharm Bull; 2010; 33(8):1364-70. PubMed ID: 20686233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
    Stange U; Führling C; Gieseler H
    J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
    Mostafa HF; Ibrahim MA; Sakr A
    Pharm Dev Technol; 2013; 18(2):454-63. PubMed ID: 22881389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.